PSMB9 and nasopharyngeal carcinoma: Our centre reported the early phase study of adenovirus transfected LMP1 and LMP2 into DC as a cell-based vaccine in advanced pre-treated, chemo-refractory NPC patients but this yielded very modest objective clinical efficacy.